Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract

[1]  J. Hocking,et al.  The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis. , 2015, The Journal of antimicrobial chemotherapy.

[2]  S. Plitt,et al.  Evidence for increased Chlamydia case finding after the introduction of rectal screening among women attending 2 Canadian sexually transmitted infection clinics. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  J. Hocking,et al.  Treatment of rectal chlamydia infection may be more complicated than we originally thought. , 2014, The Journal of antimicrobial chemotherapy.

[4]  C. Hoebe,et al.  Antibiotic Use before Chlamydia and Gonorrhea Genital and Extragenital Screening in the Sexually Transmitted Infection Clinical Setting , 2014, Antimicrobial Agents and Chemotherapy.

[5]  R. Guy,et al.  Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  R. Challenor,et al.  Rectal Chlamydia in heterosexual women: more questions than answers , 2014, International journal of STD & AIDS.

[7]  C. Hoebe,et al.  High co-occurrence of anorectal chlamydia with urogenital chlamydia in women visiting an STI clinic revealed by routine universal testing in an observational study; a recommendation towards a better anorectal chlamydia control in women , 2014, BMC Infectious Diseases.

[8]  R. Rank,et al.  Hidden in Plain Sight: Chlamydial Gastrointestinal Infection and Its Relevance to Persistence in Human Genital Infection , 2014, Infection and Immunity.

[9]  R. Rank,et al.  Differential Susceptibilities to Azithromycin Treatment of Chlamydial Infection in the Gastrointestinal Tract and Cervix , 2013, Antimicrobial Agents and Chemotherapy.

[10]  R. Rank,et al.  Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection. , 2013, Pathogens and disease.

[11]  H. Handsfield.  Questioning azithromycin for chlamydial infection. , 2011, Sexually transmitted diseases.

[12]  J. Greene,et al.  Hidden in plain sight marketing prescription drugs to consumers in the twentieth century. , 2010, American journal of public health.

[13]  A. Davies,et al.  Incidence and reinfection rates of genital chlamydial infection among women aged 16–24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group , 2006, Sexually Transmitted Infections.

[14]  C. Lau,et al.  Azithromycin Versus Doxycycline for Genital Chlamydial Infections: A Meta-Analysis of Randomized Clinical Trials , 2002, Sexually transmitted diseases.

[15]  L. Perry,et al.  Chlamydial Colonization of Multiple Mucosae following Infection by Any Mucosal Route , 1999, Infection and Immunity.

[16]  E. Hook,et al.  Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance. , 1999, Sexually transmitted diseases.

[17]  K. Workowski,et al.  Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. Evidence against persistent infection. , 1993, JAMA.

[18]  R. Sweet,et al.  Prospective study of perinatal transmission of Chlamydia trachomatis. , 1986, JAMA.